BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38284237)

  • 1. New insight into prurigo nodularis: Proadrenomedullin N-terminal 20 peptide mediates mouse mast cell activation via Mrgprb2.
    Shao Y; Xiao Z; Jin Y; Zhu Y; Shen Y; Jin T; Tang H; Wang D
    Skin Res Technol; 2024 Feb; 30(2):e13588. PubMed ID: 38284237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist.
    Bawazir M; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H
    Front Immunol; 2022; 13():1033794. PubMed ID: 36275683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-trans-retinoic acid activated mast cells via Mas-related G-protein-coupled receptor-X2 in retinoid dermatitis.
    Zheng Y; Che D; Peng B; Hao Y; Zhang X; He L; Geng S
    Contact Dermatitis; 2019 Sep; 81(3):184-193. PubMed ID: 31006867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thimerosal induces skin pseudo-allergic reaction via Mas-related G-protein coupled receptor B2.
    Peng B; Che D; Hao Y; Zheng Y; Liu R; Qian Y; Cao J; Wang J; Zhang Y; He L; Geng S
    J Dermatol Sci; 2019 Sep; 95(3):99-106. PubMed ID: 31558225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Mast-Cell-Expressed Mas-Related G-Protein-Coupled Receptors Drives Non-histaminergic Itch.
    Meixiong J; Anderson M; Limjunyawong N; Sabbagh MF; Hu E; Mack MR; Oetjen LK; Wang F; Kim BS; Dong X
    Immunity; 2019 May; 50(5):1163-1171.e5. PubMed ID: 31027996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeic acid phenethyl ester inhibits pseudo-allergic reactions via inhibition of MRGPRX2/MrgprB2-dependent mast cell degranulation.
    Adhikari N; Shim WS
    Arch Pharm Res; 2022 Sep; 45(9):644-657. PubMed ID: 36183260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRK2 differentially regulates FcεRI and MRGPRB2-mediated responses in mast cells.
    Thapaliya M; Ali H
    Front Immunol; 2023; 14():1155777. PubMed ID: 37063868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod-related dermatitis is mainly mediated by mast cell degranulation via Mas-related G-protein coupled receptor B2.
    Hao Y; Peng B; Che D; Zheng Y; Kong S; Liu R; Shi J; Han H; Wang J; Cao J; Zhang Y; Gao J; He L; Geng S
    Int Immunopharmacol; 2020 Apr; 81():106258. PubMed ID: 32044660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target.
    Chen E; Chuang LS; Giri M; Villaverde N; Hsu NY; Sabic K; Joshowitz S; Gettler K; Nayar S; Chai Z; Alter IL; Chasteau CC; Korie UM; Dzedzik S; Thin TH; Jain A; Moscati A; Bongers G; Duerr RH; Silverberg MS; Brant SR; Rioux JD; Peter I; Schumm LP; Haritunians T; McGovern DP; Itan Y; Cho JH
    Gastroenterology; 2021 Apr; 160(5):1709-1724. PubMed ID: 33421512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast Cells Initiate Type 2 Inflammation through Tryptase Released by MRGPRX2/MRGPRB2 Activation in Atopic Dermatitis.
    Jia T; Che D; Zheng Y; Zhang H; Li Y; Zhou T; Peng B; Du X; Zhu L; An J; Geng S
    J Invest Dermatol; 2024 Jan; 144(1):53-62.e2. PubMed ID: 37482287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells
    Thapaliya M; Amponnawarat A; Tesmer JJG; Ali H
    Front Immunol; 2022; 13():1032497. PubMed ID: 36275707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroquinone-induced skin irritant reaction could be achieved by activating mast cells via mas-related G protein-coupled receptor X2.
    Zheng Y; Du X; Zhang L; Jia T; Zhang H; Peng B; Hao Y; Tong Z; Che D; Geng S
    Exp Dermatol; 2023 Apr; 32(4):436-446. PubMed ID: 36463492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells, cortistatin, and its receptor, MRGPRX2, are linked to the pathogenesis of chronic prurigo.
    Kolkhir P; Pyatilova P; Ashry T; Jiao Q; Abad-Perez AT; Altrichter S; Vera Ayala CE; Church MK; He J; Lohse K; Metz M; Scheffel J; Türk M; Frischbutter S; Maurer M
    J Allergy Clin Immunol; 2022 Jun; 149(6):1998-2009.e5. PubMed ID: 35283140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of substance P and PAMP(9-20) on different excitation sites of MRGPRX2 induces differences in mast cell activation.
    Che D; Zheng Y; Hou Y; Du X; Jia T; Zhao Q; Song X; Zhou T; Geng S
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108342. PubMed ID: 34753104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactic acid suppresses MRGPRX2 mediated mast cell responses.
    Syed M; Kammala AK; Callahan B; Oskeritzian CA; Subramanian H
    Cell Immunol; 2021 Oct; 368():104422. PubMed ID: 34399172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRGPRX2 sensing of cationic compounds-A bridge between nociception and skin diseases?
    Corbière A; Loste A; Gaudenzio N
    Exp Dermatol; 2021 Feb; 30(2):193-200. PubMed ID: 33107136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin inhibits Mrgprx2-induced pseudo-allergic reaction via PLCγ-IP3R related Ca
    Ding Y; Che D; Li C; Cao J; Wang J; Ma P; Zhao T; An H; Zhang T
    Int Immunopharmacol; 2019 Jan; 66():185-197. PubMed ID: 30471617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2X4 receptor stimulation enhances MrgprB2-mediated mast cell activation and pseudoallergic reactions in mice.
    Yoshida K; Tanihara S; Miyashita Y; Obayashi K; Ito MA; Yamamoto K; Imai T; Matsuoka I
    Sci Rep; 2022 Nov; 12(1):18613. PubMed ID: 36329102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P analogs devoid of key residues fail to activate human mast cells
    Raj S; Hlushak S; Arizmendi N; Kovalenko A; Kulka M
    Front Immunol; 2023; 14():1155740. PubMed ID: 37228611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Store-Operated Calcium Entry via STIM1 Contributes to MRGPRX2 Induced Mast Cell Functions.
    Occhiuto CJ; Kammala AK; Yang C; Nellutla R; Garcia M; Gomez G; Subramanian H
    Front Immunol; 2019; 10():3143. PubMed ID: 32038646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.